thomas robert retweeted
Nephrologists! Check out this new series of review articles published by @MassGenBrigham researchers on genetic nephrology: doi.org/10.1016/j.semnephrol… @janewitwong @MGBKidneys
thomas robert retweeted
🥸2️⃣0️⃣ These findings highlight the need for caution when considering aspirin for primary prevention in older adults. In this population, long-term use *may* not be associated with cardiovascular benefit and bleeding risks remain a concern.
thomas robert retweeted
🎥Watch Dr Laurent Mesnard present the NDT publication:
CKDx is a good start - But can we go further?
oup.cloud.panopto.eu/Panopto…
thomas robert retweeted
Just out in Nature Reviews Nephrology.
Kidney stone disease: risk factors, pathophysiology and management.
nature.com/articles/s41581-0…
thomas robert retweeted
🧐Read this interesting debate in NDT!
*CKDx: a necessary step—but can we go further?
🆓doi.org/10.1093/ndt/gfaf138
*CKDx: simplicity matters, implementation is key
🆓doi.org/10.1093/ndt/gfaf137
thomas robert retweeted
📽️Watch Dr Laurent Mesnard present the NDT publication:
CKDx is a good start - But can we go further?
oup.cloud.panopto.eu/Panopto…
thomas robert retweeted
Nephrogenomics, precision medicine and the role of genetic testing in adult kidney disease management nature.com/articles/s41581-0…
thomas robert retweeted
Ongoing discussion about UACR or UPCR in glomerulonephritis captured by @NDTsocial
Albuminuria predicts kidney events in IgAN
academic.oup.com/ndt/article…
thomas robert retweeted
Replying to @ross_prager @eddyjoemd
Recent paper exploring the mechanism of benefit of calcium in hyperkalemia
pubmed.ncbi.nlm.nih.gov/3904…
thomas robert retweeted
✊ UN ENGAGEMENT #PATIENT DANS L'OMBRE #dialyse
✨
Je suis ravi de partager notre article scientifique : "Being autonomous in dialysis... " 🚶♀️➡️
👉 Lire l'article : linkedin.com/posts/fabrice-h…
#recherche #patientpartenaire
thomas robert retweeted
💡Le saviez-vous ?
A travers cette vidéo, Dr Thomas Robert, Néphrologue à l'Hôpital Saint Joseph, présente cette spécialité peu connue du grand public :
👉Qu'est-ce-que la néphrogénomique ?
👉Quand consulter ?
👉Pour qui ?
Pour en savoir plus, RDV sur notre site internet !
thomas robert retweeted
Happy to share our work publish at @NEJM !!
This achievement represents a significant step forward in transplantation. Proud to be part of this! @MGHSurgery @mgh_transplant @LVRiella
nejm.org/doi/full/10.1056/NE…
thomas robert retweeted
Hamburg news: Anti-nephrin autoantibodies in steroid-resistant nephrotic syndrome @Kidney_Int. Thanks to @hengel_f @NicolaMTomas, Franz Schäfer and @ISGDtweets. @HCKH_Hamburg @uke @ISNkidneycare @ISNWCN kidney-international.org/art…
thomas robert retweeted
Depuis 11 ans, mon blog 'Réalités Biomédicales' vit grâce à votre soutien. Chaque lecture et partage compte. Si vous trouvez mes articles intéressants, un retweet est un petit geste qui fait une grande différence.
Merci🙏
Signé : un journaliste freelance
lemonde.fr/blog/realitesbiom…
thomas robert retweeted
Important publication from the working group led by @etiennecavalier
Recommendations for European laboratories based on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease - Read on degruyter.com/document/doi/1… @degruyter_brill
thomas robert retweeted
🚨Should They Donate a Kidney?🚨
Genetic risks in living donors—when to test, counsel, and say NO! 🧬🚫
📖 C.P. Thomas et al. @amjtransplant
🔗 🆓 doi.org/10.1016/j.ajt.2023.0…
📸 Flowchart below!
#KidneyTransplant #LivingDonor #Transplant #Nephrology #Genetic #MedTwitter
thomas robert retweeted
🎥Watch Dr Victor Fages present the NDT publication:
Exon locations of glycine substitutions impacts kidney survival in autosomal dominant Alport Syndrome
oup.cloud.panopto.eu/Panopto…
thomas robert retweeted
Now online in @NDTsocial
Exon location of glycine substitutions impacts kidney survival in autosomal-dominant Alport Syndrome
🧐Gly substitution at distal exons negatively impacts on kidney survival in ADAS, probably due to a trimerization defect
▶️academic.oup.com/ndt/article…
thomas robert retweeted
🚨🚨🚨Published in KI Reports: Our multicenter study reveals that early thrombotic microangiopathy occurs in 6.1% of ABO-incompatible KT. 📢 Key findings highlight predictive antibody titers and treatment strategies with plasmapheresis & eculizumab. kireports.org/article/S2468-…


























